Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/20424114

Cancer Res. 2010 May 15 70 10 3915-24

Download in:

View as

General Info

PMID
20424114